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Secondary diversification of the B cell repertoire by
immunoglobulin gene somatic hypermutation in the
germinal center (GC) is essential for providing the
high-affinity antibody specificities required for long-
term humoral immunity. While the risk to self-toler-
ance posed by inadvertent generation of self-reac-
tive GC B cells has long been recognized, it has not
previously been possible to identify such cells and
study their fate. In the current study, self-reactive B
cells generated de novo in the GC failed to survive
when their target self-antigen was either expressed
ubiquitously or specifically in cells proximal to the
GC microenvironment. By contrast, GC B cells that
recognized rare or tissue-specific self-antigens
were not eliminated, and could instead undergo
positive selection by cross-reactive foreign antigen
and produce plasma cells secreting high-affinity
autoantibodies. These findings demonstrate the
incomplete nature of GC self-tolerance and may
explain the frequent association of cross-reactive,
organ-specific autoantibodies with postinfectious
autoimmune disease.
INTRODUCTION
Diversification of T and B lymphocyte antigen receptors is funda-
mental to immunity. In the case of B cell antigen receptors
(BCRs), clonal diversification of the antigen-combining sites
occurs in two phases. The first takes place during early B cell
development when unique combinations of V, (D), and J DNA
segments are assembled to form the immunoglobulin (Ig) heavy
and light chain variable region genes. The products of these
genes combine to define the distinct antigen-binding capabilities
of the BCRs expressed on each cell within the primary B cell
repertoire. Depending on their BCR binding-specificity, naive B
cells may recognize and be activated by structures associated
with foreign cells or molecules. Collaboration with antigen-acti-
vated CD4+ T helper (Th) cells follows, leading to the proliferativeIexpansion of activated B cells followed by their differentiation
into either terminally differentiated antibody-secreting plasma
cells or germinal center (GC) B cells (Goodnow et al., 2010; Ma-
cLennan, 1994, 2003).
GCs are areas of intense B cell proliferation that form around
the follicular dendritic cell (FDC) networks within the follicles of
secondary lymphoid tissues and also contain specialized T follic-
ular helper (Tfh) cells (Allen and Cyster, 2008; King et al., 2008). It
is typically within GCs that the second phase of BCR diversifica-
tion occurs via somatic hypermutation (SHM), the introduction of
point mutations into the Ig heavy and light chain variable region
coding exons. Rare GC B cell clones that acquire increased
affinity for foreign antigen undergo positive selection, whereby
they preferentially survive, proliferate, and ultimately undergo
plasma cell differentiation. This process of ‘‘affinity maturation’’
is driven by competition between GC B cells for foreign antigen
presented in immune complexes on the FDC surface and the
subsequent delivery of cognate help from TFH cells (Allen and
Cyster, 2008; Goodnow et al., 2010; Tarlinton, 2008; Victora
et al., 2010). Thus the secondary diversification of BCRs coupled
with affinity maturation in GCs provides the high-affinity serum
antibodies that mediate long-term humoral immunity and form
the basis of most successful vaccines (Plotkin et al., 2008).
The essentially random nature of the genetic mechanisms
responsible for generating antigen receptor diversity means
that the production of lymphocyte clones capable of recognizing
components of host tissues (i.e., self-antigens) is inevitable.
Indeed, up to 75% of newly generated bone marrow B cells
express BCRs that bind to self-antigens (Wardemann et al.,
2003). In order to benefit from lymphocyte diversity, therefore,
the immune system has evolved a parallel series of ‘‘self-toler-
ance’’ mechanisms through which the participation of self-reac-
tive lymphocytes in destructive autoimmune responses is largely
prevented. In the case of the primary B cell repertoire, the self-
tolerance mechanisms responsible for eliminating, editing, or
silencing self-reactive B cells have been extensively character-
ized (Goodnow, 1992; Nemazee, 1993; Nossal, 1994). This has
been achieved largely through the application of genetically
modified mouse models that have allowed BCR specificities
within the primary repertoire to be directed toward a natural or
transgene-encoded self-antigen. By contrast, the dynamic and
complex nature of GCs has so far thwarted attempts to identify
and study self-reactive B cells generated during the formationmmunity 37, 893–904, November 16, 2012 ª2012 Elsevier Inc. 893
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Self-Reactivity in the Germinal Center Reactionof the secondary repertoire by SHM. This has greatly limited
insights into how self-tolerance is enforced in the GC and
how residual self-reactive GC B cells may contribute to
autoimmunity.
The potential for B cells to acquire self-reactivity via SHM has
been verified both in vitro (Casson and Manser, 1995; Diamond
and Scharff, 1984) and in vivo (Olee et al., 1992; Shlomchik
et al., 1990; Shlomchik et al., 1987; Tiller et al., 2007). The
demonstration that somatically mutated, pathogenic autoanti-
bodies can emerge from the GC indicates that self-tolerance
within the secondary B cell repertoire is not absolute. Neverthe-
less, several studies suggest that self-reactive GCB cells may be
eliminated following interaction with self-antigen. These include
experiments in which the injection of a bolus of exogenous
antigen has resulted in widespread apoptosis of antigen-specific
GC B cells (Han et al., 1995; Pulendran et al., 1995; Shokat and
Goodnow, 1995) and a model in which class-switched IgG2a+ B
cells are eliminated by a transgenically encoded anti-IgG2a
‘‘superantigen’’ (Aı¨t-Azzouzene et al., 2010). Evidence also exists
that naive B cells that have some self-reactivity can emerge from
the GC having lost self-reactivity as a result of SHM (Casson and
Manser, 1995; Guay et al., 2004; Notidis et al., 2002). Although it
would appear that self-reactive GC B cells may be inactivated
under some circumstances, the current absence of a model
with which to identify bona fide self-reactive B cells generated
within the GC has made it difficult to determine how these cells
are inactivated and under what circumstances this does or
does not occur.
Here we have described a new experimental model that
allows the precise identification and analysis of B cells
acquiring self-reactivity in the GC. In particular, this model
examines those GC B cells that represent the greatest autoim-
mune threat; that is, the self-reactive clones that acquire self-
reactivity via SHM but retain the potential to undergo positive
selection by foreign antigen. Selection against such self-reac-
tive clones was found to occur but to be critically dependent
on the concentration and location of self-antigen expression.
Moreover, the data indicate that competition for self versus
foreign antigen in the GC microenvironment is fundamental
in determining the fate of self-reactive specificities generated
by SHM.
RESULTS
A Model for Investigating Self-Reactive GC B Cells:
HEL3X and HEL4X as Homologous Foreign and
Self-Antigens
The first requirement for an experimental model to identify and
study self-reactive GC B cells was a population of B cells that
possessed a defined and well-characterized BCR specificity.
In addition, a pair of homologous foreign and self antigens
were required such that: (1) the foreign but not the self-antigen
binds to the BCR (i.e., naive B cells are not self-reactive) and
(2) somatically mutated GC B cells gaining increased affinity
for the foreign-antigen also acquire cross-reactivity with the
self-antigen (see Figure S1A available online).
As a basis for this model, B cells derived from the SWHEL line of
Ig transgenic mice were utilized. B cells from SWHEL mice
express BCRs with the specificity of the HyHEL10 monoclonal894 Immunity 37, 893–904, November 16, 2012 ª2012 Elsevier Inc.antibody and thus bind to the foreign protein hen-egg lysozyme
(HEL) with high affinity (Padlan et al., 1989; Phan et al., 2003).
Because the VDJ exon of HyHEL10 is targeted to the endoge-
nous Ig heavy chain locus, anti-HEL SWHEL B cells undergo
normal Ig class switching and SHM (Phan et al., 2006). To facil-
itate studies of affinity maturation using SWHEL B cells, we previ-
ously developed HEL3X, a recombinant form of HEL with three
amino-acid substitutions in the HyHEL10 binding site (Paus
et al., 2006) (Figure 1A). The binding of HEL3X to HyHEL10 is of
intermediate affinity (Ka = 1.1 3 10
7 M1) and is readily detect-
able by direct ELISA (Figure 1C). Despite its reduced affinity for
the SWHEL BCR, HEL
3X coupled to sheep red blood cells
(HEL3X-SRBC) elicits a strong in vivo proliferative response
from donor (CD45.1 congenic) SWHEL B cells upon adoptive
transfer into wild-type (WT) recipient mice (Figure 1E). This
response includes the formation of GCs by donor SWHEL B cells
in which somatically mutated, high-affinity, anti-HEL3X clones
accumulate due to positive selection (Phan et al., 2006). The
great majority of these affinity-matured SWHEL GC B cells carry
a canonical Y53D substitution in the Ig heavy chain variable
region, which results in a >100-fold increase in the affinity of
HyHEL10 for HEL3X (Phan et al., 2006).
To develop a self-antigen to use in partnership with HEL3X
foreign antigen, we introduced an additional amino acid substi-
tution (K97R) into the HyHEL10 binding site of HEL3X. The result-
ing recombinant protein was designated HEL4X (Figure 1B).
Although HEL4X maintained a quantifiable affinity for HyHEL10
(Ka = 2.3 3 10
5 M1), the very low affinity of this interaction
made it undetectable by ELISA (Figure 1C). Moreover, HEL4X
proved incapable of triggering a measurable in vitro response
from SWHEL B cells (Figures S1B–3E) and could not elicit
a response from SWHEL B cells in vivo when conjugated to
SRBCs (Figure 1E). However, HEL4X was found to bind strongly
(Ka = 2.83 10
7 M1) to Y53D-substituted HyHEL10 (Figures 1D).
Thus HEL4X does not have a biologically relevant interaction with
the initial SWHEL BCR but does bind to the Y53D mutated form
selected during the GC response of SWHEL B cells to HEL
3X-
SRBC.
Transgenic Mice Expressing Membrane-Bound HEL4X
as a Self-Antigen
To establish a system in which HEL4X was expressed as a bona
fide self-antigen, a line of mice was required that expressed
HEL4X from a stably integrated transgene. To this end, mice
were produced carrying a cDNA encoding a membrane-bound
form of HEL4X (mHEL4X) driven by a ubiquitously expressed
promoter (UBC) and introduced as a single copy into the
ROSA26 locus (Figure 2A; Figure S2). Two separate lines of
mice were derived in which a polyadenylation site flanked by
loxP recombination sequences was either present or absent
from between the promoter and cDNA sequences (Figure 2A).
In mice lacking the polyadenylation site (mHEL4X Tg mice),
mHEL4X self-antigen was expressed in all tissues examined
(Figure 2B). Flow cytometric analysis demonstrated the pres-
ence of mHEL4X on all tested hematopoietic cell types from
mHEL4X Tg mice (Figure 2C). Immunofluorescence histology
also indicated that mHEL4X self-antigen was expressed
throughout the spleens of these mice, including in GCs
(Figure 2D).
Figure 1. Production of HEL4X and Demon-
stration of Its Binding to Y53D-Substituted
but Not WT HyHEL10
(A and B) Space filling models of HEL3X (A)
and HEL4X (B). Residues involved in HyHEL10
binding are yellow with substitutions common to
HEL3X and HEL4X in red and the substitution
unique to HEL4X (K97R) in blue.
(C and D) ELISA of the binding of recombinant
IgG1 mAbs HyHEL10 (C) and HyHEL10Y53D (D) to
HEL3X (red) and HEL4X (blue).
(E) Flow cytometry of spleen cells from WT
(CD45.2+) recipient mice 5 days after injection with
CD45.1 congenic SWHEL B cells and the indicated
SRBC conjugate. SWHEL B cells express the WT
form of HyHEL10 as their BCR and proliferate in
response to HEL3X-SRBC but not unconjugated
SRBC or HEL4X-SRBC. Plots are representative of
three independent experiments and comprise
concatenated data from two recipient mice.
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Positive Selection of Cross-Reactive GC B Cells
To determine the fate of GC B cells that cross-react with a ubiq-
uitous self-antigen, donor SWHEL B cells were injected into
mHEL4X Tg or control WT recipient mice and challenged with
HEL3X-SRBC foreign antigen. Under these circumstances,
IgG1 is the major class switched isotype expressed by respond-
ing SWHEL B cells (Chan et al., 2009). Flow cytometric analysis of
donor SWHEL GC B cells (CD45.1
+, B220+, CD38low) in WT recip-
ients revealed that clones with increased affinity for HEL3X accu-
mulated between days 5 and 14 of the response (Figure 3A). As
predicted by the binding of Y53D-substituted HyHEL10 to HEL4X
(Figure 1D), SWHEL GC B cells undergoing affinity maturation to
HEL3X foreign antigen in WT recipients also developed cross-
reactivity with HEL4X by day 14 of their response to HEL3X-
SRBC (Figure 3B).
In mHEL4X Tg recipient mice, the response of donor SWHEL B
cells to HEL3X-SRBC generated normal frequencies of both
IgG1+ and IgG1 GC B cells on day 5 (Figure 3C). By day 14,
affinity maturation of SWHEL GC B cells to HEL
3X foreign antigenImmunity 37, 893–904, Nwas apparent in mHEL4X Tg recipients
(Figure 3C). In contrast to WT recipients,
however, development of cross-reactivity
with HEL4X was absent (Figure 3D). Thus,
while affinity maturation of SWHEL GC B
cells in response to HEL3X foreign antigen
could operate in mHEL4X Tg recipients,
HEL3X-binding clones that cross-reacted
with mHEL4X self-antigen were appar-
ently prevented from undergoing positive
selection. Immunohistology analysis
confirmed that the selection of GC
phenotype B cells occurred within GC
structures in spleens from both recipient
genotypes (Figure S3).
To obtain a clearer picture of how
mHEL4X self-antigen expression was
shaping the GC response to HEL3X-SRBC, SHM analysis was performed by sequencing the Ig heavy
chain variable region exon from single SWHEL GC B cells isolated
on days 14 and 35. The most strongly selected mutations were
those resulting in the Y53D and Y58F substitutions (Figure 3E).
As expected, GC B cell clones carrying the Y53D substitution
dominated in WT recipients. However, Y53D+ clones were virtu-
ally absent fromGCB cells in mHEL4X Tgmice (Figure 3E, Tables
S1 and S2). The Y58F substitution, by contrast, was selected in
GCs from both WT and mHEL4X Tg recipients. As a result, GC
responses in WT recipients were dominated initially by
Y53D+,Y58F and subsequently by Y53D+,Y58F+ clones,
whereas GC responses in mHEL4X Tg recipients primarily
selected Y53D,Y58F+ B cells (Figure 3F).
Analysis of recombinant HyHEL10 IgG1 antibodies carrying
the Y53D and/or Y58F substitutions revealed that each bound
HEL3X foreign antigen with increased affinity compared to WT
HyHEL10 (Figures 4A and 4B). On the other hand, binding to
HEL4X in ELISA was apparent for HyHEL10 molecules carrying
Y53D (with or without Y58F) but not when Y58F was present
alone (Figure 4B). This was consistent with the relativeovember 16, 2012 ª2012 Elsevier Inc. 895
Figure 2. Construction of mHEL4X Tg Mice
and Analysis of mHEL4X Expression
(A) Diagrammatic representation of the flox-
mHEL4X transgene and derivation of the mHEL4X
transgene with Cre. UBC, human ubiquitin C
promoter; pA, polyadenylation sites; triangles,
loxP sites; oval, residual FRT site (see Figure S2).
(B) Immunoprecipitation and protein immunoblot
analysis of mHEL4X expression in tissues from WT
(–) and mHEL4X Tg (+) mice.
(C) Expression of mHEL4X on spleen cell subpop-
ulations from mHEL4X Tg mice (open histograms)
revealed by staining with HyHEL9. Grey histo-
grams represent WT controls.
(D) Fluorescence immunohistology of spleen
sections from WT (top panels) and mHEL4X Tg
(bottom panels) mice. B cell follicles (Fo, anti-IgD,
blue), GCs (PNA, red), and mHEL4X expression
(anti-HEL, green) are shown. Data are represen-
tative of spleens from six individual mice of each
genotype from two independent experiments.
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(Y53D+,Y58F+ Ka = 1.1 3 10
8 M1; Y53D+,Y58F Ka = 2.8 3
107 M1; Y53D,Y58F+ Ka = 8.9 3 10
5 M1. Figure 4A; Fig-
ure S4). Serum IgG1 antibody responses to HEL3X-SRBC in
recipient mice, which we have shown previously to be derived
exclusively from donor SWHEL B cells in this experimental
system (Phan et al., 2005), were as predicted by specificities
detected in the GC. Thus, whereas antibodies binding HEL3X
foreign antigen were generated in both WT and mHEL4X Tg
recipients, large amounts of anti-HEL4X IgG1 were only de-
tected in WT recipients (Figure 4C). These data demonstrate
that self-reactive anti-HEL4X (Y53D+) GC B cells are effectively
prevented from undergoing positive selection in mHEL4X Tg
mice, despite their high-affinity cross-reactivity with HEL3X
foreign antigen (Ka > 3 3 10
9 M1, Figure 4A). However,
clones that instead acquired increased affinity for HEL3X
foreign antigen while avoiding high-affinity cross-reactivity
with HEL4X self antigen (e.g., Y53D,Y58F+) escaped negative
selection, underwent normal positive selection, and contrib-
uted to an affinity-matured antibody response against the
HEL3X foreign-antigen.896 Immunity 37, 893–904, November 16, 2012 ª2012 Elsevier Inc.Reduced Self-Antigen Expression
Raises the Affinity Threshold of GC
B Cell Self-Tolerance
To assess the impact of reduced concen-
trations of self-antigen expression on the
development of cross-reactive GC B
cells, SWHEL B cells and HEL
3X-SRBC
were injected into recipient mice ex-
pressing low but detectable amounts of
mHEL4X (flox-mHEL4X Tg) (Figure 5A)
from the same ubiquitously expressed
UBC promoter utilized by mHEL4X Tg
mice (Figure 2A). In contrast to responses
in mHEL4X Tg recipients, SWHEL donor
GC B cells in flox-mHEL4X Tg mice
acquired increased affinity for HEL4Xself-antigen, albeit not as high as that observed in WT recipients
(Figure 5B). Consistent with this, day 21 SHM analysis revealed
that approximately half the GC B cells present in flox-mHEL4X
Tg mice had undergone positive selection for the Y53D substitu-
tion (Figure 5C; Figure S5), which bestowed strong binding to
HEL4X (Ka = 2.8 3 10
7 M1, Figure 4A; Figure S4). However,
the Y58F substitution, which increased the affinity of Y53D+
clones for HEL4X by a further 4-fold (Ka = 1.1 3 10
8 M1, Fig-
ure 4A; Figure S4), was not strongly selected in flox-mHEL4X
Tg recipients and only rarely present in conjunction with Y53D
(Figure 5C; Figure S5). In contrast to mHEL4X Tg recipients,
flox-mHEL4X Tg mice contained high titers of anti-HEL4X IgG1
antibodies in their serum (Figure 5D). Thus, whereas low expres-
sion of HEL4X self-antigen prevented positive selection of the
highest affinity self-reactive GCB cells (Y53D+,Y58F+), self-reac-
tive Y53D+,Y58FGC B cells persisted in these mice and gener-
ated a clear, affinity matured, class-switched autoantibody
response. These data show that competition between foreign
and self-antigen, impacted upon by both their relative concen-
trations and affinities for the BCR, is fundamental in determining
whether self-reactive GC B cells can be positively selected by
Figure 3. Failure of Self-Reactive GCBCells
to Develop in mHEL4X Tg Mice
(A–D) Switching to IgG1 and HEL3X versus HEL4X
binding capabilities of SWHEL GC B cells on days 5
and 14 of responses to HEL3X-SRBC. Data
represent donor SWHEL GC B cells (CD45.1
+,
CD45.2, B220+, CD38lo) in WT (A and B) and
mHEL4X Tg (C and D) recipients. Plots comprise
concatenated data from three mice and repre-
sentative of three independent experiments (n = 2–
4 per experimental group).
(E) Single cell SHM analysis of the IgH V-region of
SWHEL GC B cells on day 35. Grey columns indi-
cate the percentage of donor-derived GC B cell
clones carrying substitutions at each amino acid
residue. Colored bars indicate specific substitu-
tions present in >20% of clones in WT and/or
mHEL4X Tg recipients on day 35.
(F) Single cell SHM analysis of SWHEL GC B cells
on days 14 and 35. Sectors indicate fraction of
clones with the indicated combinations of Y53D
and Y58F substitutions. Clones analyzed are as
follows: WT recipients (d.14, n = 32; d.35, n = 22)
and mHEL4X Tg recipients (d.14, n = 28; d.35, n =
29). Data from each group are derived from two
mice. ****p < 0.0001.
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response (Figure S6).
GC Proximal Expression of Self-Antigen Is Required to
Prevent Positive Selection of Self-Reactive GC B Cells
To examine the impact of the location of self-antigen expression
on self-reactive GC B cells, we next utilized a series of Cre-trans-
genic mouse lines crossed with flox-mHEL4X Tg mice to express
high concentrations of mHEL4X in a tissue and/or cell-type-
specificmanner (Figure S6). Thesemice again acted as recipients
for SWHEL B cells together with HEL
3X-SRBC foreign antigen.
Specific expression of mHEL4X on recipient B cells (Cd19-cre)
(Rickert et al., 1997) (Figure 6A), which locate within and closely
around GCs in the spleen, resulted in a virtual absence of
Y53D+ SWHEL B cell clones in splenic GCs (Figure 6D) and pre-
ventedthedevelopmentofanti-HEL4Xserumantibody (Figure6E).Immunity 37, 893–904, NThis replicated the phenotype of tolerant
mHEL4X Tg recipients (Figures 4 and 6E)
despite the fact that Cd19-cre x flox-
mHEL4X Tg recipients expressed much
lower overall concentrations of mHEL4X
in the spleen (Figure 6C). By contrast,
Cre-dependent expression of mHEL4X in
liver hepatocytes (Alb-cre) (Postic et al.,
1999) (Figure 6B) or the glomerular podo-
cytes of the kidney (NPHS2-cre) (Moeller
et al., 2003) and with no associated
increase in splenic mHEL4X expression
(Figure 6C), did not affect either the accu-
mulation of self-reactive Y53D+ B cells in
the GC (Figure 6D) nor the production of
anti-HEL4X autoantibodies (Figure 6E).
Thus, although the specific expression ofrelatively low amounts of self-antigen proximal to the GC micro-
environment effectively prevented the positive selection of self-
reactive GCB cells, this was not true of the same self-antigen ex-
pressed at high concentrations in distal organs. Localization of
self-antigen proximal to the GC is therefore crucial to preventing
positive selection and autoantibody-production by cross-reac-
tive GC B cells (Figure S6).
Compensatory, Affinity-Reducing Mutations Permit
Long-Term Survival of Y53D+ GC B Cells
Although self-antigen expressed proximal to the GC could effec-
tively override positive selection of cross-reactive B cells gener-
ated in the GC, rare clones carrying apparently forbidden Y53D+
and Y53D+,Y58F+ self-reactive SWHEL specificities were routinely
found in GCs from mHEL4X Tg and flox-mHEL4X Tg mice chal-
lengedwithHEL3X-SRBC(Figure5C).Although thesecouldsimplyovember 16, 2012 ª2012 Elsevier Inc. 897
Figure 4. High-Affinity Autoantibodies Are
Not Produced in mHEL4X Tg Mice
(A) Distribution of affinities for HEL3X and HEL4X of
WT HyHEL10 as well as specific HyHEL10
mutants carrying Y53D and/or Y58F substitutions
(see Figure S4).
(B) ELISA of the binding of the indicated recombi-
nant HyHEL10 molecules to HEL3X and HEL4X.
Binding to HEL4X is apparent in HyHEL10 carrying
Y53D (with or without Y58F) but not Y58F alone.
(C) ELISA of HEL3X and HEL4X binding by serum
IgG1 on day 21 of SWHEL B cell responses to
HEL3X-SRBC.mHEL4XTgmice fail to produce anti-
HEL4X IgG1. Lines indicate titration data of sera
from individual recipients, black lines representing
data from unimmunized WT mice.
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the GC, we sought to explore their significance in more detail.
Reasoning that such cells may be expanded in the presence of
stronger selection by foreign antigen, we analyzed the responses
of SWHELB cells inWT, flox-mHEL
4XTgandmHEL4X Tg recipients
challenged on day 0 with HEL3X-SRBC foreign antigen as previ-
ously but also boosted with HEL3X-SRBC 4 or 5 days later.
BoostingwithHEL3X-SRBC resulted in a 3- to 4-fold increase in
the total number of SWHEL GC B cells observed on day 21 of
responses in recipients of all genotypes (data not shown).
However, it failed to increase either the frequency of self-reactive
(HEL4X-binding) GCB cells (Figure 7A versus 5B) or the amount of
anti-HEL4X IgG1 (Figure 7B versus 5D) produced in recipients ex-
pressingeither low (flox-mHEL4XTg)orhigh (mHEL4XTg) amounts
of mHEL4X self-antigen. Paradoxically, boosting mHEL4X Tg
recipients with HEL3X-SRBC foreign antigen resulted in a 4-fold
increase in the frequency of SWHEL GC B cells carrying the
Y53D substitution, such that they comprised40% of the popu-
lation by day 21 of the response (Figure 7C versus 5C). On further
analysis, the Y53D+ clones inmHEL4X Tg recipientswere found to898 Immunity 37, 893–904, November 16, 2012 ª2012 Elsevier Inc.contain unusually high frequencies of
substitutions in and around CDR1 and
CDR3 coding regions of the Ig heavy-
chain variable region, as well as in certain
framework coding regions (Table S5). A
group of specific mutations were present
in Y53D+ GC B cell clones from mHEL4X
Tg, but not WT recipients (Tables S3 and
S5), suggesting that these mutations
may reduce rather than enhance the
affinity of theSWHELBCR forHEL
3X and/or
HEL4X.
To test this proposition, we introduced
these substitutions (L4F, I29S, S31N,
S31Y, D32E, Y33F, Y58H, N94K; Table
S5) into Y53D+ HyHEL10 IgG1 antibodies
and their effect on HEL4X-binding activity
assessed by ELISA. In each case, the
binding of Y53D+ HyHEL10 to HEL4X
was either greatly reduced or rendered
undetectable (Figure S7A). These muta-
tions were present in 76% of the Y53D+GCBcell clones sequenced fromHEL3X-SRBCboostedmHEL4X
Tg recipients (Figure 7D; Table S5). An additional 14% contained
mutations predicted to reduce HEL4X-binding by Y53D+
HyHEL10 based on their homology with verified inactivating
mutations (N94H, N94R) or nonconservative substitution of
a knownHEL contact residue (T30I) (Figure 7D; Table S5). Impor-
tantly, all modified Y53D+ HyHEL10 molecules retained higher
affinities for foreign antigen (HEL3X) than the original HyHEL10
SWHEL BCR (Figure S7B). Althoughwe cannot exclude the possi-
bility that mutations that were not analyzed here may impact on
reactivity with HEL3X and HEL4X, our analysis does suggest that
Y53D+GCBcells inmHEL4X Tgmice persist if they possess addi-
tional somatic mutation(s) that (1) decrease their affinity for self-
antigen (HEL4X) (Figure S7A) but (2) maintain increased affinity
for foreign antigen (HEL3X) (Figure S7B).
DISCUSSION
The threat to self-tolerance posed by SHM of the Ig variable
region genes in GC B cells has been recognized since the
Figure 5. Self-Reactive GCBCells Are Posi-
tively Selected and Produce Autoantibodies
in flox-mHEL4X Tg Mice
(A) Immunoprecipitation and protein immunoblot
analysis of mHEL4X expression in total spleen from
the indicated mice. Low but detectable amounts
of mHEL4X were found in flox-mHEL4X Tg mice.
(B) Switching to IgG1 and HEL4X binding capabil-
ities of SWHEL GC B cells on day 21 of responses
to HEL3X-SRBC. Self-reactive, HEL4X-binding GC
B cells were detected in flox-mHEL4X but not
mHEL4X Tg mice. Plots are representative of 14
independent experiments (n = 3–6 per experi-
mental group) and comprise concatenated data
from three mice.
(C) Single cell SHM analysis of SWHEL GC B cells
on day 21. Clones analyzed: WT (n = 31 from 10
mice), flox-mHEL4X Tg (n = 43 from ten mice), and
mHEL4X Tg (n = 38 from ten mice).
(D) Endpoint titer (left) and titration (right) analysis
of anti-HEL4X IgG1 in day 21 sera. Titration data is
displayed as for Figure 4C, with data from the
additional flox-mHEL4X Tg recipient group shown
in blue. Data is representative of seven indepen-
dent experiments analyzed at day 21. ****p <
0.0001, ***p < 0.001, **p = 0.001 to 0.01; ns = not
significant.
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been made in determining the fate of self-reactive B cells
produced by primary BCR diversification in the bone marrow,Immunity 37, 893–904, Nthe dynamic and complex nature of
SHM and selection within the GC has
made it extremely difficult to identify and
ascertain the fate of self-reactive B cells
generated during this secondary phase
of BCR diversification (Chan and Brink,
2012). The experimental model described
here represents an important step
forward in understanding how self-toler-
ance is enforced in the GC and how it
may fail and give rise to autoimmunity.
Thus, by challenging SWHEL B cells with
HEL3X in the context of mHEL4X self-
antigen expression, we have developed
the ability to (1) identify bona fide self-
reactive B cells generated by SHM in
the GC and (2) examine the fate of these
cells when their target self-antigen is ex-
pressed at varying concentrations and
in different locations.
Our major findings were that (1) self-
reactive B cells can be effectively
removed from the GC regardless of
cross-reactivity with foreign antigen, (2)
their removal depends on sufficient
expression of the target self-antigen
within or proximal to the GC, and (3)
self-reactive GC B cells can escape dele-
tion, undergo positive selection byforeign antigen, and initiate an autoantibody response if target
self-antigen expression is low or physically separate from
the GC.ovember 16, 2012 ª2012 Elsevier Inc. 899
Figure 6. Failure of GC Self-Tolerance
When Self-Antigen Is Expressed Distal to
the GC
(A) Specific expression of mHEL4X on splenic B
cells from flox-mHEL4X Tg mice carrying Cd19-cre
transgene.
(B and C) Immunoprecipitation and protein
immunoblot analysis ofmHEL4X expression in total
liver or spleen from the indicated mice.
(D) Single cell SHM analysis of SWHEL GC B cells
on day 21 of SWHEL B cell responses to HEL
3X-
SRBC. Clones analyzed in flox-mHEL4X Tg with:
no Cre (n = 20), B cell Cre (n = 17), liver Cre (n = 29),
kidney Cre (n = 24). SHM data comprise pooled
data from two independent experiments (n = 6 per
experimental group).
(E) Endpoint titer data of anti-HEL4X IgG1 in day 21
sera. Data is representative of five independent
experiments. ****p < 0.0001, **p = 0.001 to 0.01,
ns = not significant.
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apparent mechanism in place to prevent self-reactive B cells
generated in the GC from producing autoantibodies directed900 Immunity 37, 893–904, November 16, 2012 ª2012 Elsevier Inc.against self-antigens expressed outside
the GC microenvironment. Thus GC B
cells that acquire reactivity with self-
antigen expressed in a distal organ such
as the liver remain susceptible to positive
selection by cross-reactive foreign
antigen and can therefore differentiate
unimpeded into autoantibody-producing
plasma cells. This failure to enforce self-
tolerance to tissue-specific self-antigens
in GC B cells stands in contrast to the
purging of B and T lymphocytes recog-
nizing this class of self-antigen at other
checkpoints during lymphocyte differen-
tiation. In the primary B cell repertoire,
for instance, B cells recognizing tissue-
specific antigens circulate through the
body in a quiescent state and can be
deleted or rendered inactive when they
encounter their cognate self-antigen (Ro-
jas et al., 2001; Russell et al., 1991).
Furthermore, specialized medullary
epithelial cells located in the thymus
purge the early T cell repertoire of many
clones reactive to distally expressed
self-antigens by presenting peptides
from these tissue-specific proteins
(Mathis and Benoist, 2009). It is likely,
therefore, that the incomplete control of
self-reactive B cells generated in the GC
represents a ‘‘weak link’’ in the mecha-
nisms that collectively enforce self-toler-
ance in the immune system.
The failure to comprehensively enforce
self-tolerance in theGCmay be attributedto the difficulty of controlling self-reactive B cells generated in
the midst of an active immune reaction against foreign antigen.
Thus, in the absence of sufficient amounts of target self-antigen
Figure 7. Boosting with Foreign Antigen
Does Not Break GC B Cell Self-Tolerance
SWHEL B cells were challenged and boosted with
HEL3X-SRBC. Data is from two independent
experiments. Antigen boost was given on day 4 or
day 5 without altering the response obtained.
(A) HEL4X binding capabilities of SWHEL GC B cells
on day 21. Plots are representative of three inde-
pendent experiments (n = 2–5 per experimental
group) and comprise concatenated data from two
mice.
(B) Endpoint titer (left) and titration (right) analysis
of anti-HEL4X IgG1 in sera from day 21 of
responses. Titration data is displayed as for Fig-
ure 5D. ***p < 0.001, ****p < 0.0001.
(C) Single cell SHM analysis of SWHEL GC B cells
on day 21. The fraction of clones with Y53D is
increased 4-fold in mHEL4X Tg mice given an
antigen boost (compare with Figure 5C). Clones
analyzed: WT (n = 48), flox-mHEL4X Tg (n = 55),
and mHEL4X Tg (n = 54). SHM data comprise
pooled data from six mice from two independent
experiments. ***p < 0.001, ****p < 0.0001.
(D) Percentage of clones containing confirmed
(orange) or likely (yellow) affinity-reducing muta-
tions within the Y53D+ and Y53D GC B cell
populations frommHEL4X Tg recipient mice (Table
S5) as well as the Y53D+ GCB cell population from
WT recipient mice (Table S3). See Figure S7 for
HEL4X and HEL3X binding analyses.
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Self-Reactivity in the Germinal Center Reactionproximal to the GC microenvironment, self-reactive GC B cells
remain ‘‘ignorant’’ of their self-reactivity and continue to receive
help from GC-resident anti-foreign TFH cells. In this way, the
production of antibodies against tissue-specific self-antigens
can proceed without the need to compromise T cell self-toler-
ance. These findings imply that autoantibody production could
emerge from any humoral immune response directed against
a foreign antigen that has some structural homology to
a tissue-specific self-antigen. Evidence that this phenomenonImmunity 37, 893–904, Noccurs during conventional immune
responses is provided by the emergence
of cross-reactive autoantibodies in re-
sponse to viral antigens (Srinivasappa
et al., 1986) and the frequent association
of cross-reactive autoantibodies with
postinfectious, tissue-specific autoim-
mune diseases such as hepatitis
C-related immune thrombocytopenia
(Zhang et al., 2009), pauci-immune focal
necrotizing glomerulonephritis (Kain
et al., 2008), Chagas disease (Cunha-
Neto et al., 2006), Guillain-Barre´
syndrome (Yuki et al., 2004), and rheu-
matic carditis (Guilherme et al., 2006).
Thus the inability of the immune system
to prevent the production of cross-reac-
tive autoantibodies from theGC response
may contribute to the onset and/or
progression of a number of human auto-
immune diseases.One of the key implications of our findings is that the balance
between the recognition of self and foreign antigens is critical to
determining the fate of self-reactive GC B cells. In this regard,
both the amount of each competing antigen type and the relative
affinity of the BCR for them each play important roles. This point
is illustrated by our finding that the reduced expression of
mHEL4X self-antigen in flox-mHEL4X Tg versus mHEL4X Tg
mice permitted the positive selection of self-reactive
Y53D+,Y58F GC B cells but still prevented the developmentovember 16, 2012 ª2012 Elsevier Inc. 901
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Self-Reactivity in the Germinal Center Reactionof the higher-affinity Y53D+,Y58F+ self-reactive clones. Mecha-
nistically, we propose that the preferential association of GC B
cells with self instead of foreign antigen prevents the reception
of sufficient stimulatory signals from foreign antigen and limits
their access to help from GC-resident TFH cells (Victora et al.,
2010). Under such circumstances, self-reactive GC B cells
would be at a competitive disadvantage compared to cells that
recognize foreign but not self-antigen and so would fail to be
propagated in the GC (eg Y53D+ versus Y53D,Y58F+ clones
in mHEL4X Tg mice).
Another possibility is that the interaction of GC B cells with self
versus foreign antigen leads to the delivery of quantitatively or
qualitatively distinct signal(s) that result in the direct killing of
self-reactive GC B cells. This may be true in particular when
self-antigen is present at high concentrations, because GC B
cells undergo rapid cell death when exposed to very high
concentrations of exogenous antigen (Han et al., 1995; Pulen-
dran et al., 1995; Shokat and Goodnow, 1995). In these models
of GC negative selection, the death of antigen-reactive GC B
cells was at least partially blocked by overexpression of the
anti-apoptotic protein Bcl-2. Interestingly, this strategy reduces
overall apoptosis in the GC and also blocks the death of GC B
cells that would otherwise be removed due to their low affinity
for foreign antigen (Smith et al., 2000). It will be of interest to
determine whether the death of bona fide self-reactive B cells
will also be blocked by overexpression of Bcl-2, or whether
potentially other members of the Bcl-2 family, such as Mcl-1
(Vikstrom et al., 2010), may play a more prominent role.
Although the form of antigen used in this study provides
a strong source of SRBC-specific T cell help to HEL3X-binding
SWHEL B cells, it is possible that the use of alternative adjuvants
and/or sources of T cell help might provide a stronger selection
for foreign antigen and thus facilitate selection of cross-reactive
GCB cells even when the target self-antigen is expressed at high
concentrations. Separate experiments in which HEL3X was
conjugated to ovalbumin and injected in alum adjuvant failed
to rescue self-reactive SWHEL GC B cells or generate anti-
HEL4X autoantibodies in mHEL4X Tg recipients (data not shown).
This result, together with demonstration here that boosting with
HEL3X-SRBC also fails to break self-tolerance in mHEL4X Tg
mice, indicates that the enforcement of GC self-tolerance is
robust when self-antigen is expressed at sufficient concentra-
tions proximal to the GC. Nevertheless, it will be of interest to
determine whether potentially stronger challenges, such as
HEL3X conjugated with TLR ligands or active pathogens, might
more readily compromise GC self-tolerance and precipitate
autoimmunity.
The results presented here reveal an exceptional capability for
SHM-coupled positive and negative selection in the GC to shape
BCR binding specificities to match the local antigen environ-
ment.While optimization of BCR affinity for foreign antigen drives
the GC reaction, avoidance of cross-reactivity with localized
self-antigen exerts a dominant influence that ultimately deter-
mines which somatic mutations can contribute to high affinity
antibodies directed against foreign antigens. On the other
hand, the failure of self-antigens expressed distal to the GC to
have any impact on the secondary B cell repertoire represents
an autoimmune risk. This ‘‘weak link’’ in self-tolerance is likely
to contribute to the production of cross-reactive autoantibodies902 Immunity 37, 893–904, November 16, 2012 ª2012 Elsevier Inc.that can recognize tissue-specific self-antigens and potentially
to the genesis of postinfectious autoimmune disease.EXPERIMENTAL PROCEDURES
HEL3X and HEL4X Proteins
HEL3X is a recombinant version of HEL that carries the R21Q, R73E, and
D101R substitutions (Paus et al., 2006). To produce HEL4X, a pIRES expres-
sion plasmid was first produced carrying a cDNA encoding a membrane-
bound form of HEL3X (mHEL3X) with the transmembrane and cytoplasmic
domains of the H-2Kk class I major histocompatibility complex (MHC) mole-
cule (Hartley et al., 1991). Candidate mHEL4X molecules were produced by
introducing a variety of amino acid substitutions at the K97 position of and ex-
pressed separately on the surface of HEK293. The substitution chosen was
K97R (Figure 1A). cDNAs encoding soluble, His-tagged versions of HEL3X
and HEL4X were cloned into the pPIC9K vector and the recombinant proteins
expressed in yeast (Pichia pastoris) and purified from culture supernatants
(Paus et al., 2006).
flox-mHEL4X Tg and mHEL4X Tg Mice
An expression construct was assembled consisting of human ubiquitin C
(UBC) promoter, loxP-flanked SV40 early polyadenylation site (pA), FRT-
flanked mHEL3X cDNA with 30 bovine growth hormone polyadenylation site,
mHEL4X cDNA with 30 bovine growth hormone polyadenylation site, murine
phosphoglycerate kinase (Pgk) promoter, neomycin resistance gene (neor)
cDNA, and a 30 splice donor sequence. A gene-targeting construct was
assembled by inserting the expression construct between 50 and 30 homology
arms from the murine ROSA26 locus (Figure S2). Gene targeting in C57BL/6
Bruce4 embryonic stem cells was performed by Ozgene (Bentley, West
Australia) and Tg foundermouse obtained carrying a single copy of the expres-
sion construct targeted to the ROSA26 locus. This founder line (flox-mHEL3X
Tg) was crossed with ACTB-FLPe (Rodrı´guez et al., 2000) mice to obtain
a germ-line deletion of the mHEL3X cDNA and produce founders for the flox-
mHEL4X Tg line. flox-mHEL4X Tg mice were in turn converted into founders
for the mHEL4X Tg line by crossing with a ROSA26-cre Tg line (Ozgene) to
obtain germ-line deletion of the floxed polyadenylation site (Figure S2). Soluble
HEL4X is detectable in sera frommHEL4X Tg mice (range 4–11 ng/ml in 6 mice)
but is undetectable (<1 ng/ml) in straight flox-mHEL4X Tg mice and all Cre Tg
crosses.
Other Mice and SWHEL B Cell Transfer Experiments
SWHEL mice (Phan et al., 2003) were bred onto a CD45.1 congenic C57BL/6
background while all other mice were maintained on a pure C57BL/6
(CD45.2+) background. All mice were bred and housed in specific path-
ogen-free conditions at Australian Bioresources (Moss Vale, Australia) and
the Garvan Institute. The following Cre Tg lines were used: Cd19-cre (Rickert
et al., 1997), Alb-cre (Postic et al., 1999), NPHS2-cre (Moeller et al., 2003).
Intravenous transfers of SWHEL B cells (33 10
4 HEL-binding B cells per recip-
ient) together with HEL3X-SRBC (2 3 108 per recipient) were performed as
described (Paus et al., 2006). All animal experiments were carried out in
accordance with the guidelines of the Garvan St Vincent’s Animal Ethics
Committee.
Flow Cytometric Analysis
Staining procedures, reagents, data acquisition, and analysis of flow cytome-
try data have been previously described (Chan et al., 2009). Between 6–12 3
106 events were collected per sample and light scatter gating performed to
exclude dead cells and debris. A further doublet exclusion gate was applied
and gates were set to exclude autofluorescent cells. GC B cells were identified
within recipient spleen cell preparations as CD45.1+, CD45.2, B220+, CD38lo
and typically comprised 0.1%–0.3% of total spleen cells. Binding of HEL3X or
HEL4X by GC B cells was revealed by staining with the unlabelled proteins
(50 ng/ml and 100 ng/ml, respectively) followed byHyHEL9-Alexa 647. Surface
expression of mHEL4X was detected directly with HyHEL9-Alexa647 and B
cell, T cell, and red blood cell (RBC) subpopulations identified using the
B220, CD3, and TER-119 lineage-specific markers, respectively.
Immunity
Self-Reactivity in the Germinal Center ReactionSingle-Cell Flow-Cytometry-Based Sorting and SHM Analysis
Cell suspensions were prepared as for flow cytometry analysis. Total donor-
derived GC B cells were identified with anti-CD45.1-FITC, anti-CD38-PE,
and anti-B220-APC. Single-cell sorting was performed on a FACSAria (BD
Biosciences), and the variable region exon of the SWHEL Ig (HyHEL10) heavy
chain gene was amplified by PCR, sequenced, and analyzed as previously
described (Paus et al., 2006).
HEL3X-and HEL4X-Binding ELISA
ELISA detection of the binding of recombinant HyHEL10 IgG1 molecules and
serum antibodies to HEL3X and HEL4Xwere performed as previously described
(Phan et al., 2003) except HEL3X or HEL4X protein coated 384-well plates
(Corning) were used. To quantify serum antibody concentrations, endpoint
titers were calculated based on 97.5% confidence levels or greater (Frey
et al., 1998).
Immunofluorescence Histology
Sections were cut and prepared as previously described (Chan et al., 2009).
Detection of mHEL4X expression was with polyclonal rabbit anti-HEL IgG
(Rockland Immunochemicals) followed by Alexa 555-conjugated anti-rabbit
IgG(H+L) (Invitrogen Molecular Probes). Naive B cells were revealed with
anti-IgD-Alexa 647 (clone 11-26c.2a, BD Biosciences) and GCs using PNA-
FITC (Vector Laboratories).
Detection of HEL4X Expression by Immunoprecipitation and Protein
Immunoblots
Equivalent tissue amounts by weight were homogenized in RIPA buffer and
immunoprecipitated at 4C using Protein G beads and purified HyHEL9mono-
clonal antibody. Immunoblotting was performed as previously described (Gar-
dam et al., 2008) with membranes probed with polyclonal rabbit anti-HEL IgG
(Rockland) followed by sheep anti-rabbit IgG-HRP (Santa Cruz).
Recombinant HyHEL10 IgG1 Antibody Production and Binding
Affinity Analysis
WT and mutant recombinant HyHEL10 IgG1 mAbs were expressed in CHO
cells as previously described (Phan et al., 2006). Biacore analysis was per-
formed at 25C using a Biacore 2000 (GEHealthcare). Anti-mouse IgG1mono-
clonal antibody (A85-1, BD Biosciences) was immobilized onto a CM5 sensor
chip (GE Healthcare) using amine coupling to attain a target density of 10,000
RU. HyHEL10 IgG1 mutants were then injected to achieve a reading of 1,000
RU. Binding of antigen was assessed by injecting serial dilutions of HEL3X or
HEL4X (5.6 mM–1.0 nM) over all flow cells at a flow rate of 30 ml/min until equi-
librium was reached. Equilibrium binding constants (Ka) were determined by
fitting sensorgrams to a 1:1 Langmuir binding model using BIAevaluation 4.1
program (GE Healthcare). Where association and dissociation rates could
not be determined using kinetic fits, binding affinity was determined by
Scatchard plot analysis using responses obtained during steady-state phase
of binding.
Statistical Analysis
Statistical significance of serum antibody endpoint titers and SHM data were
calculated using Graphpad Prism software. For endpoint titers, multiple
comparisons were performed using ANOVA analyseswith the Bonferroni post-
test and 99.9% confidence levels applied. Statistical analyses of the SHMdata
were performed using the chi-square test and 99% confidence intervals
applied.
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